
A Mount Sinai study found that blocking an allergy pathway boosts antitumor immunity in lung cancer, with an allergy drug, dupilumab, enhancing the effectiveness of immunotherapy in patients. Researchers at the Icahn School of Medicine at Mount Sinai have identified an allergy pathway that, when






                        English (US)  ·